Dr. Hart is a highly accomplished and experienced leader, innovator, and research scientist who has developed transformative, cutting-edge technologies throughout his impressive career. In 2012, Dr. Hart founded LumaCyte, a revolutionary research, instrumentation, and diagnostics company. LumaCyte offers pharmaceutical and biotechnology companies an advanced label-free approach to single-cell analysis and sorting, providing them with a powerful new system for the detection of changing cell phenotypes. Leading his team over a 12-year period of development at the Naval Research Laboratory (NRL), the core technologies underlying LumaCyte's products were born. As the original inventor of this novel technology, Dr. Hart and his team have pioneered the scientific advances that have enabled (LASERFORCE tm) cytology.Using LumaCyte's patented label-free technologies, researchers will be able to better understand the disease, accelerate the development of therapies, and discover cures for some of humankind’s most pressing health concerns.Dr. Hart has 50+ peer-reviewed journal articles, numerous invited and contributed presentations, 16 patents issued / 50 pending, and has managed large research teams with multi-million dollar budgets. Dr. Hart has extensive experience in a diverse range of research areas including virology, cell-based assays, biomanufacturing, spectroscopy, laser trapping and separation, optical engineering, chromatography, chemical and biochemical separation, statistical data analysis/calibration, and artificial intelligence. Dr. Hart received his Ph.D. in Chemistry from Tufts University in 1998. www.LumaCyte.com